In addition, a recent cross-sectional study on IS reported that a low expression of IGF-II (quartile 1) mRNA in peripheral plasma exosomes was related to stroke risk, and IGF-II was suggested as a clinical biomarker [27]. This evidence concerns the gene IGF2 and stroke disorder.